News

Technology News

Covidien Expands Endovascular Treatment Portfolio

Tuesday, September 18, 2012 5:00:00 AM PDT | VentureDeal
   Plymouth, Minnesota  --  Medical device maker Covidien (NYSE: COV) has announced the launch of a new system for the treatment of chronic total occlusions.

The Viance Crossing Catheter and Enteer Reentry System devices are now available in the US, the EU and other international locations.

The new devices provide surgeons with access to the distal end of a lesion, allowing them to treat the most challenging lesions endovascularly.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1